<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>GDPD2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ▼';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ►';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>GDPD2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9HCC8" target="_blank" class="term-link">
                        Q9HCC8
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                📝 Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "GDPD2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9HCC8" data-a="DESCRIPTION: GDPD2 (Glycerophosphoinositol inositolphosphodiest..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">👍</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">👎</button>
            </span>
        </div>
        <p>GDPD2 (Glycerophosphoinositol inositolphosphodiesterase GDPD2) is a membrane-bound enzyme that specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate. It functions as an ecto-enzyme with its catalytic domain oriented extracellularly, requiring millimolar Ca2+ as a cofactor. GDPD2 plays a critical role in promoting osteoblast differentiation and serves as a marker of osteoblast maturation. The protein localizes to the plasma membrane as a multi-pass membrane protein and colocalizes with actin filaments, suggesting involvement in cytoskeletal remodeling during cell differentiation.</p>
    </div>
    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0005886" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Plasma membrane localization is well-supported by experimental evidence. GDPD2 is a multi-pass membrane protein with transmembrane segments that anchor it in the membrane, with its catalytic domain oriented extracellularly. UniProt and literature confirm this membrane localization is essential for its ecto-enzyme function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Strong experimental evidence from biochemical and cell biology studies confirms GDPD2 as a plasma membrane protein with multiple transmembrane passes. The extracellular orientation of the catalytic domain and requirement for membrane anchoring to process extracellular glycerophosphoinositol support this core cellular component annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 is a multi-pass membrane protein predominantly localized at the plasma membrane. Topology studies indicate that it spans the membrane multiple times, anchoring the protein at the cell surface.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008889" target="_blank" class="term-link">
                                    GO:0008889
                                </a>
                            </span>
                            <span class="term-label">glycerophosphodiester phosphodiesterase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0008889" data-r="GO_REF:0000033" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This term is correct but less specific than the actual enzymatic activity. GDPD2 has been experimentally characterized as having glycerophosphoinositol inositolphosphodiesterase activity (GO:0047394), which is a more specific child term that precisely describes its substrate specificity for glycerophosphoinositol.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GDPD2 does possess glycerophosphodiester phosphodiesterase activity, experimental evidence demonstrates it specifically acts on glycerophosphoinositol and not on other glycerophosphodiesters like glycerophosphocholine or glycerophosphoethanolamine. The more specific term GO:0047394 better captures this substrate specificity.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047394" target="_blank" class="term-link">
                                    glycerophosphoinositol inositolphosphodiesterase activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate, glycerophosphocholine, -ethanolamine, or -serine</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0005737" data-r="GO_REF:0000044" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is misleading as GDPD2 is primarily a plasma membrane protein with its catalytic domain oriented extracellularly. While there may be some cytoplasmic association via its transmembrane segments or interaction with cytoskeletal elements, the primary and functionally relevant localization is the plasma membrane, not the cytoplasm.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GDPD2 is a multi-pass transmembrane protein with its functional catalytic domain on the extracellular side of the plasma membrane. The cytoplasm annotation likely comes from automatic mapping but does not reflect the actual topology and functional localization of the protein. The plasma membrane annotation already captures the correct localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">The catalytic domain resides on the extracellular side of the membrane, consistent with the finding that glycerophosphoinositol is hydrolyzed in the extracellular medium by overexpressed GDPD2</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005856" target="_blank" class="term-link">
                                    GO:0005856
                                </a>
                            </span>
                            <span class="term-label">cytoskeleton</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000044
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0005856" data-r="GO_REF:0000044" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> While GDPD2 colocalizes with actin filaments and may associate with the cytoskeleton, the more specific term GO:0005884 (actin filament) better captures this interaction. The broad cytoskeleton term is too general.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Evidence indicates GDPD2 specifically colocalizes with actin filaments rather than the cytoskeleton in general. The protein appears to concentrate at sites of actin-rich membrane structures and influences cell morphology, suggesting a specific association with the actin cytoskeleton rather than other cytoskeletal components.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005884" target="_blank" class="term-link">
                                    actin filament
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                    GO:0005886
                                </a>
                            </span>
                            <span class="term-label">plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0005886" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This plasma membrane annotation is correct and consistent with experimental evidence. This IEA annotation independently supports the IBA annotation for the same term, confirming plasma membrane localization through different computational methods.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Multiple lines of evidence including transmembrane domain predictions, experimental topology studies, and functional characterization all confirm GDPD2 as a plasma membrane protein. This annotation correctly captures a core cellular component for this protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 is a multi-pass membrane protein predominantly localized at the plasma membrane</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006629" target="_blank" class="term-link">
                                    GO:0006629
                                </a>
                            </span>
                            <span class="term-label">lipid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0006629" data-r="GO_REF:0000002" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This broad term is correct but vague. GDPD2 specifically catalyzes the hydrolysis of glycerophosphoinositol, a glycerophospholipid metabolite. More specific terms like glycerophospholipid metabolic process (GO:0006650) or phospholipid catabolic process would be more informative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GDPD2 is involved in lipid metabolism, its specific function is the catabolism of glycerophosphoinositol, a glycerophospholipid derivative. A more specific biological process term would better represent its actual metabolic role.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006650" target="_blank" class="term-link">
                                    glycerophospholipid metabolic process
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2s unique lipid substrate specificity ties it to lipid metabolic processes, particularly the catabolism of glycerophosphoinositol lipids</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0008081" target="_blank" class="term-link">
                                    GO:0008081
                                </a>
                            </span>
                            <span class="term-label">phosphoric diester hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0008081" data-r="GO_REF:0000002" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is a correct parent term for GDPD2s enzymatic activity, but too general. The more specific glycerophosphoinositol inositolphosphodiesterase activity (GO:0047394) should be used as it precisely describes the substrate specificity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> GDPD2 does have phosphoric diester hydrolase activity, but experimental characterization has shown it specifically acts on glycerophosphoinositol. Using the more specific molecular function term provides better functional annotation.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047394" target="_blank" class="term-link">
                                    glycerophosphoinositol inositolphosphodiesterase activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 encodes an enzyme with glycerophosphoinositol inositolphosphodiesterase activity (EC 3.1.4.43)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016787" target="_blank" class="term-link">
                                    GO:0016787
                                </a>
                            </span>
                            <span class="term-label">hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0016787" data-r="GO_REF:0000043" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This extremely broad term is correct but uninformative. GDPD2 has been experimentally characterized with specific glycerophosphoinositol inositolphosphodiesterase activity, which should be the primary molecular function annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct that GDPD2 is a hydrolase, this term is too general to be useful. The specific enzymatic activity (glycerophosphoinositol inositolphosphodiesterase) has been experimentally determined and should be the focus of molecular function annotations.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047394" target="_blank" class="term-link">
                                    glycerophosphoinositol inositolphosphodiesterase activity
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046872" target="_blank" class="term-link">
                                    GO:0046872
                                </a>
                            </span>
                            <span class="term-label">metal ion binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0046872" data-r="GO_REF:0000043" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is correct but could be more specific. GDPD2 specifically requires Ca2+ as a cofactor for its enzymatic activity. The more specific term calcium ion binding (GO:0005509) would be more informative.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Experimental evidence shows GDPD2 specifically requires millimolar Ca2+ as a cofactor for its catalytic activity. The calcium ion binding annotation would more precisely represent this metal ion requirement.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005509" target="_blank" class="term-link">
                                    calcium ion binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+ as a cofactor</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">The active site of the GP-PDE domain requires divalent cations for catalysis – notably Ca2+ acts as a cofactor to facilitate bond cleavage</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047394" target="_blank" class="term-link">
                                    GO:0047394
                                </a>
                            </span>
                            <span class="term-label">glycerophosphoinositol inositolphosphodiesterase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0047394" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation precisely captures the experimentally determined enzymatic activity of GDPD2. Multiple studies have confirmed that GDPD2 specifically hydrolyzes glycerophosphoinositol to produce glycerol and inositol 1-phosphate, with no activity on other glycerophosphodiesters.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the most specific and accurate molecular function annotation for GDPD2. Experimental evidence clearly demonstrates this specific enzymatic activity (EC 3.1.4.43) with strict substrate specificity for glycerophosphoinositol. This represents the core molecular function of the protein.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate, glycerophosphocholine, -ethanolamine, or -serine</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005884" target="_blank" class="term-link">
                                    GO:0005884
                                </a>
                            </span>
                            <span class="term-label">actin filament</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0005884" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> GDPD2 colocalizes with actin filaments according to literature and database annotations. This association may be related to its role in cell morphology changes during osteoblast differentiation, though this represents a secondary localization compared to its primary plasma membrane residence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GDPD2 does colocalize with actin filaments, this is not its primary localization or core function. The protein is primarily a plasma membrane ecto-enzyme, and the actin association may be relevant for its effects on cell morphology during differentiation but is not essential for its enzymatic function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">In addition to the cell surface, GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions), potentially linking its enzymatic activity to cytoskeletal remodeling</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007015" target="_blank" class="term-link">
                                    GO:0007015
                                </a>
                            </span>
                            <span class="term-label">actin filament organization</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0007015" data-r="GO_REF:0000107" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> There is some evidence that GDPD2 influences cell morphology and cytoskeletal arrangement, particularly during osteoblast differentiation. However, this appears to be an indirect effect of its enzymatic activity rather than a direct role in actin organization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Changes in cell morphology were observed upon altering GDPD2 levels, suggesting involvement in cytoskeletal remodeling. However, this is likely a downstream effect of its lipid metabolic activity and role in differentiation rather than a direct function in actin organization. This represents a peripheral rather than core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 has been associated with actin cytoskeleton organization, as changes in cell morphology and cytoskeletal arrangement were observed upon altering GDPD2 levels</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">experiments noted GDPD2s influence on cell shape and morphology, supporting a role at the interface of the plasma membrane and the actin cytoskeleton</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030027" target="_blank" class="term-link">
                                    GO:0030027
                                </a>
                            </span>
                            <span class="term-label">lamellipodium</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0030027" data-r="GO_REF:0000107" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> There is no strong experimental evidence specifically placing GDPD2 in lamellipodia. While GDPD2 colocalizes with actin and may be at membrane ruffles, specific lamellipodium localization has not been demonstrated experimentally.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation appears to be an over-interpretation based on actin colocalization. While GDPD2 may be present at actin-rich membrane structures, there is no direct evidence for specific lamellipodium localization. The plasma membrane and actin filament annotations already capture the relevant cellular localizations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045669" target="_blank" class="term-link">
                                    GO:0045669
                                </a>
                            </span>
                            <span class="term-label">positive regulation of osteoblast differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9HCC8" data-a="GO:0045669" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">👍</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">👎</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This annotation is strongly supported by experimental evidence. GDPD2 is upregulated during osteoblast maturation and overexpression promotes osteoblast differentiation with increased alkaline phosphatase activity and mineralization. This represents a core biological function of GDPD2.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Multiple experimental studies demonstrate that GDPD2 promotes osteoblast differentiation. It is considered a marker of osteoblast maturation, and overexpression accelerates the osteogenic program. This is one of the best-characterized biological roles of GDPD2 and represents a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">Overexpression of GDPD2 (GDE3) in osteoblastic cells has been shown to promote osteoblast differentiation, evidenced by increased alkaline phosphatase activity and mineralized calcium deposition</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/GDPD2/GDPD2-deep-research.md
                                    
                                </span>
                                
                                <div class="support-text">GDPD2 accelerates the program of osteoblast differentiation and growth</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Glycerophosphoinositol-specific phosphodiesterase activity with calcium-dependent catalysis at the plasma membrane</h3>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="FUNCTION: Glycerophosphoinositol-specific phosphodiesterase ..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">👍</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">👎</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0047394" target="_blank" class="term-link">
                            glycerophosphoinositol inositolphosphodiesterase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006650" target="_blank" class="term-link">
                                glycerophospholipid metabolic process
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045669" target="_blank" class="term-link">
                                positive regulation of osteoblast differentiation
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005886" target="_blank" class="term-link">
                                plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/GDPD2/GDPD2-deep-research.md
                            
                        </span>
                        
                        <div class="finding-text">This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>Calcium ion binding required for enzymatic activity</h3>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="FUNCTION: Calcium ion binding required for enzymatic activit..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">👍</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">👎</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005509" target="_blank" class="term-link">
                            calcium ion binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006650" target="_blank" class="term-link">
                                glycerophospholipid metabolic process
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/GDPD2/GDPD2-deep-research.md
                            
                        </span>
                        
                        <div class="finding-text">GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+ as a cofactor</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000044.md" target="_blank" class="term-link">
                            GO_REF:0000044
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods.</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/GDPD2/GDPD2-deep-research.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep Research Report on GDPD2</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">GDPD2 colocalizes with actin filaments and may influence cytoskeletal remodeling</div>
                        
                        <div class="finding-text">"GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions), potentially linking its enzymatic activity to cytoskeletal remodeling"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the physiological concentration of extracellular glycerophosphoinositol in bone tissue and how does it change during osteoblast differentiation?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: bone_biology, lipid_metabolism</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="Q: What is the physiological concentration of extrace..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">👎</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Does GDPD2 have any additional substrates beyond glycerophosphoinositol under specific cellular conditions?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: enzymology, biochemistry</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="Q: Does GDPD2 have any additional substrates beyond g..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">👎</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are the downstream signaling effects of the inositol 1-phosphate product generated by GDPD2 activity?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: cell_signaling, phosphoinositide_biology</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="Q: What are the downstream signaling effects of the i..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">👎</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> Is GDPD2 activity regulated by post-translational modifications or protein-protein interactions during osteoblast differentiation?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: protein_biochemistry, bone_biology</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="Q: Is GDPD2 activity regulated by post-translational ..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">👎</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the functional significance of GDPD2 colocalization with actin filaments at the plasma membrane?</p>
                    
                    <p style="margin-top: 0.5rem;"><em>Suggested experts: cell_biology, cytoskeleton</em></p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="Q: What is the functional significance of GDPD2 coloc..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">👎</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> GDPD2 knockout mouse model to assess skeletal phenotype</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Loss of GDPD2 will result in decreased bone density and impaired osteoblast differentiation in vivo</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: GENETIC_MANIPULATION</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="EXPERIMENT: GDPD2 knockout mouse model to assess skeletal phen..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">👎</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Live-cell imaging of fluorescently-tagged GDPD2 during osteoblast differentiation</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: GDPD2 localization and dynamics change during the transition from proliferating to differentiating osteoblasts</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: CELL_BIOLOGY</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="EXPERIMENT: Live-cell imaging of fluorescently-tagged GDPD2 du..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">👎</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Mass spectrometry-based lipidomics to measure glycerophosphoinositol levels in GDPD2-overexpressing vs control cells</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: GDPD2 overexpression will deplete extracellular glycerophosphoinositol pools and alter downstream lipid metabolites</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: BIOCHEMISTRY</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="EXPERIMENT: Mass spectrometry-based lipidomics to measure glyc..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">👎</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Co-immunoprecipitation and proximity labeling to identify GDPD2 protein interaction partners</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: GDPD2 forms complexes with cytoskeletal proteins or other membrane-associated signaling molecules</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: PROTEOMICS</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="EXPERIMENT: Co-immunoprecipitation and proximity labeling to i..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">👎</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Structure determination of GDPD2 catalytic domain by X-ray crystallography or cryo-EM</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: Structural analysis will reveal the molecular basis for substrate specificity and calcium dependence</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: STRUCTURAL_BIOLOGY</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q9HCC8" data-a="EXPERIMENT: Structure determination of GDPD2 catalytic domain ..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">👍</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">👎</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">📚 Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(GDPD2-deep-research.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9HCC8" data-a="DOC: Deep Research" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">👍</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">👎</button>
                </div>
            </summary>
            <div class="markdown-content">
                <h1 id="deep-research-report-gdpd2-human">Deep Research Report: GDPD2 (human)</h1>
<p>Generated using OpenAI Deep Research API</p>
<p>UniProt ID: Q9HCC8<br />
Directory alias: GDPD2</p>
<hr />
<h1 id="gene-function-and-molecular-mechanisms">Gene Function and Molecular Mechanisms</h1>
<p>GDPD2 (glycerophosphodiester phosphodiesterase domain-containing protein 2), also known as <strong>GDE3</strong>, encodes an enzyme with glycerophosphoinositol inositolphosphodiesterase activity (EC 3.1.4.43) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Function%20%20,1%3B%20Type%3DFrameshift%3B%20Positions%3D397%3B%20Evidence%3D">lipidmaps.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>). This enzyme specifically hydrolyzes <strong>glycerophosphoinositol (GroPIns)</strong> into glycerol and inositol 1-phosphate, and notably <em>does not</em> act on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate, glycerophosphocholine, -ethanolamine, or -serine (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Function%20%20,By%20similarity">lipidmaps.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=analyses%20show%20that%20wild,an%20arginine%20residue%20crucial%20for">pmc.ncbi.nlm.nih.gov</a>). GDPD2 functions as an <strong>ecto-enzyme</strong>, requiring millimolar Ca<sup>2+</sup> as a cofactor, and its catalytic domain is oriented extracellularly (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Caution%20%20,role%20in%20remodeling%20of%20the">lipidmaps.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=GDE3%20activity,activity%2C%20this%20predicts%20an%20enzyme">pmc.ncbi.nlm.nih.gov</a>). As a result, it hydrolyzes <strong>extracellular</strong> GroPIns without altering the intracellular pool (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Caution%20%20,role%20in%20remodeling%20of%20the">lipidmaps.org</a>). A critical <strong>arginine residue (Arg-231)</strong> in the catalytic GP-PDE domain is required for activity, as mutation of this residue abolishes enzymatic function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=analyses%20show%20that%20wild,an%20arginine%20residue%20crucial%20for">pmc.ncbi.nlm.nih.gov</a>). Through its enzymatic action, GDPD2 is thought to modulate signaling pathways involving GroPIns, which has been implicated in cell growth and differentiation signals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>). Consistently, GDPD2 activity has been linked to changes in cell morphology, suggesting downstream effects on cytoskeletal or membrane dynamics (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>).  </p>
<h1 id="cellular-localization-and-subcellular-components">Cellular Localization and Subcellular Components</h1>
<p>GDPD2 is a <strong>multi-pass membrane protein</strong> predominantly localized at the <strong>plasma membrane</strong> (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Similarity%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). Topology studies indicate that it spans the membrane multiple times, anchoring the protein at the cell surface (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Similarity%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). The catalytic domain resides on the <strong>extracellular side</strong> of the membrane, consistent with the finding that glycerophosphoinositol is hydrolyzed in the extracellular medium by overexpressed GDPD2 (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Caution%20%20,role%20in%20remodeling%20of%20the">lipidmaps.org</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=GDE3%20activity,activity%2C%20this%20predicts%20an%20enzyme">pmc.ncbi.nlm.nih.gov</a>). In addition to the cell surface, GDPD2 has been observed in the <strong>cytoplasm associated with the cytoskeleton</strong>, co-localizing with <strong>actin filaments</strong> (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Similarity%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions), potentially linking its enzymatic activity to cytoskeletal remodeling. Indeed, experiments noted GDPD2’s influence on cell shape and morphology (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>), supporting a role at the interface of the plasma membrane and the actin cytoskeleton. Key Gene Ontology (GO) cellular component terms for GDPD2 include <strong>“integral component of membrane”</strong> (plasma membrane) and <strong>“actin cytoskeleton”</strong>, reflecting these localizations (<a href="https://hmdb.ca/proteins/HMDBP11530#:~:text=lipid%20metabolic%20process%20Cellular%20Component,activity%2C%20acting%20on%20ester%20bonds">hmdb.ca</a>).  </p>
<h1 id="biological-processes-involvement">Biological Processes Involvement</h1>
<p>GDPD2 is strongly implicated in <strong>bone formation and osteoblast differentiation</strong>. Its expression and activity are up-regulated during the maturation of osteoblasts (bone-forming cells), and it is considered a <strong>marker of osteoblast differentiation</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>). Overexpression of GDPD2 (GDE3) in osteoblastic cells has been shown to <strong>promote osteoblast differentiation</strong>, evidenced by increased alkaline phosphatase activity and mineralized calcium deposition (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=match%20at%20L45%20alkaline%20phosphatase,proliferation%2C%20in%20line%20with%20the">pmc.ncbi.nlm.nih.gov</a>). This suggests GDPD2 accelerates the osteogenic program and the growth of bone tissue, aligning with its UniProt annotation that it “<strong>accelerates the program of osteoblast differentiation and growth</strong>” (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=inositolphosphodiesterase%20activity%20and%20specifically%20hydrolyzes,show%20less">www.proteinatlas.org</a>). Conversely, GDPD2 activity appears to <strong>modulate cell proliferation</strong>; as osteoblasts differentiate, proliferation slows, indicating GDPD2 may help switch cells from a proliferative state to a mature, mineralizing state (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=match%20at%20L45%20alkaline%20phosphatase,proliferation%2C%20in%20line%20with%20the">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>). Beyond skeletogenesis, GDPD2’s unique lipid substrate specificity ties it to <strong>lipid metabolic processes</strong>, particularly the catabolism of glycerophosphoinositol lipids (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>). By hydrolyzing GroPIns, GDPD2 could influence signaling pathways (GroPIns is known to partake in cell signaling and growth control (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7960645/#:~:text=Direct%20LC,containing%20molecules%2C%20may%20prevent%20in">pmc.ncbi.nlm.nih.gov</a>)), thus impacting processes like cell growth, differentiation, and possibly apoptosis in certain contexts. Additionally, GDPD2 has been associated with <strong>actin cytoskeleton organization</strong>, as changes in cell morphology and cytoskeletal arrangement were observed upon altering GDPD2 levels (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>). This supports a proposed role in actin filament remodeling, which could affect cell migration or shape. Relevant GO terms for processes include <strong>“lipid catabolic process”</strong>, <strong>“osteoblast differentiation”</strong>, and <strong>“actin cytoskeleton organization”</strong>, consistent with current evidence (<a href="https://hmdb.ca/proteins/HMDBP11530#:~:text=lipid%20metabolic%20process%20Cellular%20Component,activity%2C%20acting%20on%20ester%20bonds">hmdb.ca</a>) (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=inositolphosphodiesterase%20activity%20and%20specifically%20hydrolyzes,show%20less">www.proteinatlas.org</a>).  </p>
<h1 id="disease-associations-and-phenotypes">Disease Associations and Phenotypes</h1>
<p>To date, there are no well-established hereditary diseases directly caused by mutations in <strong>GDPD2</strong> in humans. GDPD2 is located on the X chromosome (Xq13.1), but no X-linked disorder has been definitively tied to this gene. However, given its role in bone differentiation, researchers have considered that GDPD2 dysfunction might impact bone density or skeletal development. In mice, Gde3 (GDPD2) is highly expressed in osteocytes and late-stage osteoblasts (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>), suggesting that loss of this enzyme could potentially affect bone formation or turnover; nevertheless, published mouse knockout phenotypes for Gdpd2 have not been prominently reported, implying either a subtle effect or functional compensation by related enzymes. There are some intriguing correlative findings in human data: <strong>The Human Protein Atlas</strong> reports that GDPD2 RNA is <strong>enhanced in certain cancers</strong>, such as glioblastoma multiforme, and elevated in some cancer cell lines (e.g. bladder carcinoma cell lines) (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2#:~:text=Cancer%20specificity,i%7D%20No">www.proteinatlas.org</a>). This cancer-enhanced expression hints at a possible role in tumor biology (perhaps through altering cellular growth or motility), but currently there is no direct evidence linking GDPD2 to oncogenesis or specific cancer phenotypes. Similarly, large-scale genomic studies have not highlighted GDPD2 in common disease contexts, aside from occasional text-mined associations that are not yet experimentally confirmed. In summary, while <strong>GDPD2’s importance in bone differentiation is clear, its involvement in human disease remains to be fully determined</strong>, and it is a subject for future investigation.  </p>
<h1 id="protein-domains-and-structural-features">Protein Domains and Structural Features</h1>
<p>GDPD2 is a member of the <strong>glycerophosphoryl diester phosphodiesterase (GP-PDE) family</strong> of enzymes (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Similarity%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). It contains a single <strong>GP-PDE catalytic domain</strong> that confers its enzymatic activity of cleaving glycerophosphodiester bonds (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Similarity%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). Characteristic of this family, GDPD2 has several <strong>hydrophobic transmembrane segments</strong> near its N-terminus that anchor the protein in the membrane, with computational predictions and experimental data indicating <strong>multiple transmembrane passes</strong> (multi-pass membrane protein architecture) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Subcellular%20Location%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). The N-terminus likely includes a signal peptide or leader sequence targeting the protein to the secretory pathway, ensuring the catalytic domain is presented in the luminal/extracellular space (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Caution%20%20,role%20in%20remodeling%20of%20the">lipidmaps.org</a>). The <strong>active site</strong> of the GP-PDE domain requires divalent cations for catalysis – notably Ca<sup>2+</sup> acts as a cofactor to facilitate bond cleavage (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Caution%20%20,role%20in%20remodeling%20of%20the">lipidmaps.org</a>). An invariant arginine (Arg-231 in human GDPD2) within the domain is critical for catalysis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=analyses%20show%20that%20wild,an%20arginine%20residue%20crucial%20for">pmc.ncbi.nlm.nih.gov</a>), reflecting a conserved active-site motif important for substrate binding or phosphodiester bond breakage. Three isoforms of GDPD2 have been reported due to <strong>alternative splicing</strong> (590 amino acids in isoform 1; 539 aa in isoform 2; 460 aa in isoform 3) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=284055242%20%20,glycerophosphoinositol%20inositolphosphodiesterase%20GDPD2%20isoform%203">lipidmaps.org</a>). Isoform 1 (590 aa) is the full-length, primary form, while isoforms 2 and 3 lack certain internal segments (their existence is predicted from transcript data and not experimentally confirmed) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Alternative%20Products%20%20,the%20medium%20of%20cells%20overexpressing">lipidmaps.org</a>) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=284055242%20%20,glycerophosphoinositol%20inositolphosphodiesterase%20GDPD2%20isoform%203">lipidmaps.org</a>). These shorter isoforms may lack some transmembrane regions or functional elements, potentially altering localization or activity, although their biological significance remains unclear. <strong>Metal-binding</strong> sites (for Ca<sup>2+</sup>) and conserved catalytic residues within the GP-PDE domain define the molecular function of GDPD2 (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Gdpd2%2C%20whereas%20intracellular%20levels%20of,By%20similarity">lipidmaps.org</a>). No full crystallographic structure is yet available, but an AlphaFold predicted structure exists (based on homology modeling), which confirms the globular ectodomain and transmembrane helices consistent with the proposed topology. In summary, GDPD2’s structure comprises a membrane-anchored ecto-enzyme domain belonging to a highly conserved phosphodiesterase family, with features supporting its role in lipid substrate recognition and hydrolysis.  </p>
<h1 id="expression-patterns-and-regulation">Expression Patterns and Regulation</h1>
<p><strong>GDPD2</strong> shows a tissue-specific expression pattern that aligns with its functional role in bone. It is most prominently expressed in <strong>osteogenic lineage cells</strong> – studies in mice have shown Gde3 (GDPD2) mRNA is low in undifferentiated osteoblasts but significantly <strong>up-regulated in mature osteoblasts and osteocytes</strong> (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>). This developmental regulation suggests that transcription of GDPD2 is controlled by osteogenic differentiation programs (potentially downstream of bone-specific transcription factors or signaling pathways that drive late-stage differentiation). In humans, RNA profiling indicates that GDPD2 is expressed in a variety of tissues at moderate levels, with the highest expression noted in <strong>bone marrow, osteoblasts, and possibly certain epithelial tissues</strong> (one analysis clusters GDPD2 with genes in squamous epithelial/keratinization programs) (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2#:~:text=Cancer%20specificity,i%7D%20No">www.proteinatlas.org</a>). The Human Protein Atlas classifies GDPD2 as <strong>“tissue enhanced” in bone-related tissues</strong>, and interestingly also reports elevated expression in <strong>skin/keratinocytes and cervix</strong> (which might relate to the squamous differentiation cluster) – though these data are primarily transcript-based. At the cellular level, GDPD2 protein has been detected in the cytoplasm and membrane of osteoblastic cells. Regulation of GDPD2 expression is not fully elucidated, but given its upregulation with differentiation, it may be controlled by factors like <strong>bone morphogenetic proteins (BMPs)</strong> or other osteogenic signals. Bioinformatic promoter analyses (if any) have not been highlighted in literature, but <strong>Runx2</strong>, a master osteoblast transcription factor, could be a candidate regulator. Additionally, GDPD2 has multiple mRNA splice variants (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=Gene%20summary%20%28Entrez%29,show%20less">www.proteinatlas.org</a>), hinting at post-transcriptional regulation or tissue-specific isoform expression. There is no evidence that GDPD2 is inducible by acute stimuli (e.g., calcium, hormones) in the short term, but its expression pattern suggests <strong>regulation is tied to developmental and differentiation cues</strong>. In summary, GDPD2 is expressed broadly at low-to-moderate levels, with <strong>notable enrichment in bone-forming cells</strong>, and its gene expression is tightly linked to the differentiation status of cells. This pattern underscores its role in specialized biological contexts (bone maturation and possibly epithelial differentiation).  </p>
<h1 id="evolutionary-conservation">Evolutionary Conservation</h1>
<p>GDPD2 is evolutionarily conserved across vertebrates and is a part of an ancient enzyme family present even in bacteria. The <strong>GP-PDE enzyme family</strong> (glycerophosphodiester phosphodiesterases) was first characterized in bacteria and later identified in mammals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=The%20glycerophosphodiester%20phosphodiesterase%20enzyme%20family,Substrate%20specificity">pmc.ncbi.nlm.nih.gov</a>), indicating that organisms from prokaryotes to humans utilize related mechanisms to catabolize glycerophosphodiesters. Human GDPD2 shares significant sequence homology with its mammalian orthologs: for example, the mouse <em>Gdpd2</em> (Gde3) protein is highly similar in sequence and function (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>). GDPD2 orthologs are found in all placental mammals examined, as well as in marsupials and likely other vertebrates (e.g., birds and reptiles have GDPD2-like genes, given the presence of a <em>GDPD2</em> gene in turtle genome data (<a href="https://www.ncbi.nlm.nih.gov/gene/142020017#:~:text=GDPD2%20glycerophosphodiester%20phosphodiesterase%20domain%20containing,%7C">www.ncbi.nlm.nih.gov</a>)). Within primates, GDPD2 is well conserved (chimpanzee GDPD2 is ~99% identical to human, as expected from its essential functional role). The conservation extends to amino acids critical for catalytic activity – for instance, the Arg residue essential for activity and metal-binding motifs in the GP-PDE domain are conserved across species (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=analyses%20show%20that%20wild,an%20arginine%20residue%20crucial%20for">pmc.ncbi.nlm.nih.gov</a>). This high degree of conservation suggests strong <strong>purifying selection</strong>, implying GDPD2’s function in glycerophosphoinositol metabolism is biologically important across species. In contrast, lower eukaryotes like yeast have analogous glycerophosphodiester phosphodiesterases (e.g., yeast <em>Git1</em> and others) but these are structurally distinct glycerol-3-phosphate transporters or enzymes, not one-to-one orthologs. Among the seven mammalian GDE family members (GDE1–GDE7), GDPD2 (GDE3) has a specific niche in bone tissue, whereas other family members have diverged to fulfill roles in nervous system development (GDE2), ubiquitous signaling (GDE1), etc. (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=In%20contrast%2C%20GDE3%20has%20been,been%20correlated%20to%20its%20expression">pmc.ncbi.nlm.nih.gov</a>). The presence of this enzyme family in diverse organisms underlines its fundamental role in lipid metabolism. Thus, <strong>GDPD2 is an evolutionarily conserved gene</strong>, particularly within vertebrates, reflecting the conserved nature of glycerophosphoinositol metabolism and its importance in cellular physiology.  </p>
<h1 id="key-experimental-evidence-and-literature">Key Experimental Evidence and Literature</h1>
<p>Multiple studies have established GDPD2’s functions and characteristics. A cornerstone study by Corda <em>et al.</em> (2009) characterized <strong>mouse GDE3 (GDPD2)</strong> as a glycerophosphoinositol-specific phosphodiesterase and demonstrated its role in osteoblast differentiation (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=match%20at%20L45%20alkaline%20phosphatase,proliferation%2C%20in%20line%20with%20the">pmc.ncbi.nlm.nih.gov</a>). This study provided direct evidence of GDPD2’s substrate specificity (cleaving GroPIns but not related lipids) and showed that overexpressing GDE3 in osteoblasts increased differentiation markers (alkaline phosphatase, mineralization) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=match%20at%20L45%20alkaline%20phosphatase,proliferation%2C%20in%20line%20with%20the">pmc.ncbi.nlm.nih.gov</a>). It also revealed the requirement of Ca<sup>2+</sup> for activity and an extracellular orientation of the catalytic domain (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=GDE3%20activity,activity%2C%20this%20predicts%20an%20enzyme">pmc.ncbi.nlm.nih.gov</a>). Another key piece of evidence from the same work was the identification of Arg-231 as critical for catalysis via site-directed mutagenesis (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=analyses%20show%20that%20wild,an%20arginine%20residue%20crucial%20for">pmc.ncbi.nlm.nih.gov</a>). Following this, a review by Yanaka (2007) surveyed the <strong>mammalian glycerophosphodiester phosphodiesterase family</strong>, noting GDE3’s high expression in osteocytes and suggesting its role as a differentiation marker (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>). A 2013 <strong>Frontiers in Immunology</strong> review by Patrussi <em>et al.</em> further highlighted that GDE1 and GDE3 are ecto-enzymes that hydrolyze extracellular GroPIns, and specifically described GDE3 as predominantly expressed in bone cells (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=further%20level%20of%20modulation%20of,10">pmc.ncbi.nlm.nih.gov</a>). This review also underscored the idea that GroPIns can act as a signaling molecule in cell proliferation and that GDE3’s activity (producing inositol-1-phosphate and glycerol) might modulate such signals (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>). The Human Protein Atlas provides expression data, showing GDPD2’s enrichment in osteoblastic cells and certain cancers (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2#:~:text=Cancer%20specificity,i%7D%20No">www.proteinatlas.org</a>). Lastly, the UniProt database (Q9HCC8) and NCBI RefSeq provide curated summaries corroborating these findings, noting GDPD2’s enzymatic function, localization, and “by similarity” inferred roles in actin cytoskeleton remodeling (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=inositolphosphodiesterase%20activity%20and%20specifically%20hydrolyzes,encodes%20a%20member%20of%20the">www.proteinatlas.org</a>) (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Function%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>). Together, these literature sources form a coherent picture: <strong>GDPD2 (GDE3)</strong> is an ecto-phosphodiesterase with a specialized role in bone cell differentiation and a unique substrate specificity, supported by both experimental enzymology and cell biology evidence. Key GO annotations drawn from this body of work include <strong>glycerophosphoinositol glycerophosphodiester phosphodiesterase activity</strong>, <strong>integral component of plasma membrane</strong>, <strong>actin cytoskeleton</strong>, <strong>osteoblast differentiation</strong>, and <strong>lipid metabolic process</strong>, each backed by experimental findings (<a href="https://hmdb.ca/proteins/HMDBP11530#:~:text=lipid%20metabolic%20process%20Cellular%20Component,on%20ester%20bonds%20catalytic%20activity">hmdb.ca</a>) (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=inositolphosphodiesterase%20activity%20and%20specifically%20hydrolyzes,show%20less">www.proteinatlas.org</a>). The accumulating research thus provides a solid foundation for Gene Ontology curation of GDPD2, linking its molecular function to cellular context and biological outcomes.  </p>
<p><strong><em>References:</em></strong> Primary literature and databases were used to compile this report, including functional enzymology studies (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=topology%20with%20an%20extracellular%20catalytic,type%20GDE3%20in%20osteoblasts%20promotes">pmc.ncbi.nlm.nih.gov</a>) (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2757188/#:~:text=function%20of%20GDE3%2C%20one%20of,A">pmc.ncbi.nlm.nih.gov</a>), reviews on lipid signaling (<a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3725514/#:~:text=The%20glycerophosphodiesterases%20GDE1%20and%20GDE3%2C,coupled">pmc.ncbi.nlm.nih.gov</a>), and curated database annotations from UniProt and NCBI (<a href="https://lipidmaps.org/databases/lmpd/LMP003184#:~:text=Function%20%20,Note%3DColocalizes%20with%20the%20actin%20cytoskeleton">lipidmaps.org</a>) (<a href="https://www.proteinatlas.org/ENSG00000130055-GDPD2/summary/gene#:~:text=inositolphosphodiesterase%20activity%20and%20specifically%20hydrolyzes,encodes%20a%20member%20of%20the">www.proteinatlas.org</a>). These sources ensure that each aspect of GDPD2 – from biochemical activity to physiological role – is documented with experimental evidence appropriate for GO annotation.</p>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Falcon Research</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(GDPD2-falcon-research.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9HCC8" data-a="DOC: Falcon Research" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">👍</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">👎</button>
                </div>
            </summary>
            <div class="markdown-content">
                <h1 id="falcon-research-report-gdpd2-human">Falcon Research Report: GDPD2 (human)</h1>
<p>Generated using FutureHouse Falcon API</p>
<p>UniProt ID: Q9HCC8<br />
Directory alias: GDPD2</p>
<hr />
<p>Question: You are a molecular biologist and gene annotation expert conducting comprehensive research to support GO annotation curation.</p>
<p>Provide detailed, well-cited information focusing on:<br />
1. Gene function and molecular mechanisms<br />
2. Cellular localization and subcellular components<br />
3. Biological processes involvement<br />
4. Disease associations and phenotypes<br />
5. Protein domains and structural features<br />
6. Expression patterns and regulation<br />
7. Evolutionary conservation<br />
8. Key experimental evidence and literature</p>
<p>Format as a comprehensive research report with citations suitable for Gene Ontology annotation curation.</p>
<p>Research the Homo sapiens gene GDPD2.</p>
<p>=== UNIPROT METADATA ===<br />
UniProt ID: Q9HCC8<br />
Entry Name: GDPD2_HUMAN<br />
Gene Name: GDPD2<br />
Protein Name: Glycerophosphoinositol inositolphosphodiesterase GDPD2<br />
EC Number: 3.1.4.43<br />
Organism: Homo sapiens (Human)<br />
NCBI Taxonomy ID: 9606<br />
Function: Has glycerophosphoinositol inositolphosphodiesterase activity and specifically hydrolyzes glycerophosphoinositol, with no activity for other substrates such as glycerophosphoinositol 4-phosphate, glycerophosphocholine, glycerophosphoethanolamine, and glycerophosphoserine. Accelerates the program of osteoblast differentiation and growth. May play a role in remodeling of the actin cytoskeleton (By similarity).<br />
Subcellular Location: Cell membrane; Multi-pass membrane protein. Cytoplasm. Cytoplasm, cytoskeleton<br />
======================</p>
<p>Provide a comprehensive report covering function, localization, processes, domains, disease associations, expression, conservation, and relevant GO terms.</p>
<p>IMPORTANT: Focus specifically on the gene identified by the metadata above, particularly the UniProt ID, locus tag, and protein description if provided.</p>
<p>Sometimes different genes in the same organism have the same name. In this case, the gene being reviewed is the one identified by the metadata above.</p>
<p>I. Introduction<br />
GDPD2 (Glycerophosphoinositol inositolphosphodiesterase GDPD2, UniProt ID Q9HCC8) is a multipass transmembrane protein encoded by a gene in Homo sapiens with a predicted enzymatic activity classified under EC number 3.1.4.43. This protein is characterized by its ability to hydrolyze glycerophosphoinositol, and it has been associated with critical cellular processes such as osteoblast differentiation and actin cytoskeleton remodeling. The breadth of recent clinical and experimental investigations—evidenced by over 29,600 clinical trials that include GDPD2 and relevant phenotypes—demonstrates the high level of interest in its potential roles in bone health, cytoskeletal dynamics, and related signaling pathways (Clinical Trial Search: 83c188e3b460). This report provides a comprehensive analysis of GDPD2 with a focus on its gene function and molecular mechanisms, cellular localization, involvement in biological processes, potential disease associations, protein domains and structural features, expression regulation, evolutionary conservation, and available experimental evidence that supports its Gene Ontology (GO) annotation.  </p>
<p>II. Gene Function and Molecular Mechanisms<br />
At the molecular level, GDPD2 functions primarily as a glycerophosphoinositol inositolphosphodiesterase. Its catalytic activity is highly substrate-specific, as it hydrolyzes glycerophosphoinositol while exhibiting no measurable activity towards substrates such as glycerophosphoinositol 4-phosphate, glycerophosphocholine, glycerophosphoethanolamine, or glycerophosphoserine. This enzymatic specificity is crucial for maintaining the proper balance of phosphoinositide metabolites, which are integral to cellular signaling cascades (pintopinho2024comparativebioinformaticanalysis pages 9-11). The precise mechanism by which GDPD2 exerts its function involves the cleavage of phosphodiester bonds in the glycerophosphoinositol molecule. The resulting products may serve as secondary messengers or intermediates in further biosynthetic pathways, thereby modulating downstream signaling events. Although the detailed kinetics and three‐dimensional conformation of the active site have not been completely elucidated, sequence analysis predicts the presence of a conserved phosphodiesterase domain that is consistent with its catalytic role (pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>GDPD2 has also been implicated in the regulation of the actin cytoskeleton, an association that suggests a multifaceted role in cellular morphology and motility. The remodeling of the actin cytoskeleton, which is essential for various aspects of cell behavior including migration and adhesion, appears to be influenced by GDPD2 activity; this may occur either through direct interaction with cytoskeletal components or indirectly via the generation of lipid-derived signaling molecules. Moreover, the modulation of the actin network is an integral part of the osteoblast differentiation program, a process where precursors commit to a bone-forming lineage (pintopinho2024comparativebioinformaticanalysis pages 9-11, Clinical Trial Search: 83c188e3b460). The acceleration of osteoblast differentiation by GDPD2 suggests that its enzymatic activity could prime cells for matrix secretion and mineralization by reconfiguring local membrane domains or altering the lipid composition of the cytosol (Clinical Trial Search: 83c188e3b460, rolfe2014identificationofmechanosensitive pages 8-10). Although the exact intracellular pathways remain to be fully characterized, it is plausible that GDPD2 contributes to the activation of signaling cascades—such as those involving Wnt and other differentiation-related pathways—that are sensitive to changes in cellular phospholipid levels (rolfe2014identificationofmechanosensitive pages 8-10).</p>
<p>The molecular mechanism of GDPD2 may also involve complex interactions with other proteins, thereby participating in larger multi-protein complexes at the plasma membrane. Such interactions could facilitate the coordinated regulation of lipid metabolism and cytoskeletal dynamics, integrating external signals with internal responses. Despite the absence of detailed mapping of its interaction partners in the current context, the predicted functional motifs within GDPD2 indicate a likely role as a scaffold or regulatory element in these complexes (pintopinho2024comparativebioinformaticanalysis pages 9-11). Collectively, these attributes underscore GDPD2’s importance in cellular homeostasis and provide a biochemical rationale for its inclusion in GO annotations that reflect its enzymatic and structural roles.</p>
<p>III. Cellular Localization and Subcellular Components<br />
The subcellular localization of GDPD2 is a defining feature of its functional profile. Experimental data indicate that GDPD2 is primarily localized to the plasma membrane, where it is embedded as a multi-pass transmembrane protein (pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14). This localization is consistent with its role in mediating interactions between extracellular signals and intracellular responses through its enzymatic conversion of membrane-associated substrates. In addition to its presence in the plasma membrane, GDPD2 has been associated with the cytoplasm and the cytoskeleton, suggesting a dynamic distribution that may allow it to participate in the reorganization of cellular architecture (pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14).</p>
<p>The integration of GDPD2 into lipid bilayers appears to be facilitated by multiple transmembrane domains, which confer both stability and the appropriate orientation necessary for catalytic activity. The topology of GDPD2, including the detailed arrangement of its membrane-spanning regions, although not fully mapped in the current studies, is predicted to support interactions with cytoplasmic proteins that regulate actin filament formation and reorganization (pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14). This dual localization—anchoring in the membrane while also engaging with cytoskeletal elements—positions GDPD2 as a key mediator of signal transduction events that are critically involved in cellular processes such as motility, morphology, and differentiation.</p>
<p>Moreover, the localization of GDPD2 to specific membrane microdomains might facilitate the compartmentalization of its enzymatic activity, thereby ensuring that its substrate processing occurs in proximity to relevant signaling proteins or receptors. Such spatial regulation is especially important in the context of osteoblast differentiation, where the precise modulation of membrane lipid composition may trigger intracellular signaling cascades involved in bone formation (Clinical Trial Search: 83c188e3b460, pintopinho2024comparativebioinformaticanalysis pages 9-11). The current data underscore the need for further high-resolution studies to delineate the exact membrane localization patterns and interaction networks that define GDPD2 functionality.</p>
<p>IV. Biological Processes Involvement<br />
GDPD2 plays a multifaceted role in key biological processes that govern cell differentiation, cytoskeletal organization, and signal transduction. Its most notable function is the acceleration of osteoblast differentiation—a process essential for bone development, remodeling, and repair. The conversion of mesenchymal stem cells into osteoblasts is a complex process driven by a myriad of signaling pathways, extracellular cues, and transcriptional regulators. In this context, GDPD2 has been shown to stimulate osteoblast differentiation and growth, a function that likely depends on its capacity to modulate the lipid microenvironment at the plasma membrane (pintopinho2024comparativebioinformaticanalysis pages 9-11, Clinical Trial Search: 83c188e3b460).</p>
<p>In addition to its role in bone formation, GDPD2 is implicated in the remodeling of the actin cytoskeleton. Actin reorganization is a fundamental aspect of cellular processes such as migration, adhesion, and mechanotransduction. The remodeling of actin filaments enables cells to respond to mechanical stimuli and to adapt their shape in response to environmental changes. By influencing cytoskeletal dynamics, GDPD2 may contribute to cellular reorganization events that are crucial during developmental transitions, tissue repair, and pathological conditions characterized by cytoskeletal disarray (Clinical Trial Search: 83c188e3b460, rolfe2014identificationofmechanosensitive pages 8-10). The involvement of GDPD2 in cytoskeletal regulation is further supported by studies that indicate down-regulation of cytoskeletal genes in contexts of disturbed mechanosensitive signaling, suggesting that perturbations in GDPD2 function might influence cellular architecture (rolfe2014identificationofmechanosensitive pages 8-10).</p>
<p>The metabolic activity of GDPD2, through its hydrolysis of glycerophosphoinositol, could also play a role in modulating the levels of lipid-derived signaling molecules. These molecules may act as critical mediators of signaling pathways such as Wnt, which is known to be heavily implicated in osteogenesis and cell differentiation (rolfe2014identificationofmechanosensitive pages 8-10). Therefore, GDPD2 might act as a modulator of the paracrine or autocrine signals that regulate bone formation and cellular differentiation. Although the direct connection between GDPD2 activity and the Wnt signaling cascade remains to be thoroughly dissected, the available evidence suggests that its enzymatic function is integrated within broader regulatory networks that control cell fate decisions.</p>
<p>Emerging clinical data also suggest that variations in GDPD2 function could be associated with bone disease phenotypes. The consistent retrieval of GDPD2 in clinical trials focused on osteoblast differentiation and cytoskeletal dynamics underscores its potential involvement in pathological conditions that affect bone integrity and function (Clinical Trial Search: 83c188e3b460). These results imply that dysfunctions or aberrations in GDPD2 activity might lead to impaired osteogenesis, ultimately contributing to disorders such as osteoporosis or other skeletal abnormalities—a hypothesis that is further supported by the observed acceleration of osteoblast differentiation when GDPD2 activity is intact (Clinical Trial Search: 83c188e3b460).</p>
<p>V. Disease Associations and Phenotypes<br />
While detailed mechanistic studies directly linking GDPD2 to specific disease states remain scarce, the wealth of clinical trial data implicates this gene in a number of bone-related phenotypes and disorders. The high number of clinical trials—exceeding 29,600—that have been initiated with queries including GDPD2 and associated terms (such as osteoblast differentiation, actin cytoskeleton remodeling, and bone disease) indicates a significant research focus on the role of this protein in the pathophysiology of skeletal disorders (Clinical Trial Search: 83c188e3b460). These studies collectively suggest that abnormal regulation or expression of GDPD2 may be correlated with bone diseases and may serve as a potential biomarker or therapeutic target in conditions characterized by defective bone remodeling.</p>
<p>The acceleration of the osteoblast differentiation program by GDPD2, as indicated by experimental and clinical observations, implies that enhanced or diminished activity of GDPD2 could lead to divergent bone phenotypes. In a scenario where GDPD2 function is compromised, osteoblast differentiation may be delayed or insufficient, potentially resulting in decreased bone formation and a predisposition to osteopenia or osteoporosis (Clinical Trial Search: 83c188e3b460, rolfe2014identificationofmechanosensitive pages 8-10). Conversely, excessive or unregulated GDPD2 activity might contribute to abnormal bone growth or remodeling, possibly leading to pathological calcification or ectopic ossification. These clinical implications underscore the importance of tightly regulated GDPD2 expression and function in maintaining bone health.</p>
<p>Beyond bone-related disorders, the association of GDPD2 with actin cytoskeleton remodeling suggests that it may also have implications in diseases where cytoskeletal dynamics play a role. Dysregulation of the actin cytoskeleton is a hallmark of several pathological conditions, including certain cancers and neurodegenerative diseases. Although specific links between GDPD2 and these conditions are not yet established in the current set of literature, the functional overlap between cytoskeletal disruption and disease progression provides a compelling rationale for further investigation into GDPD2’s potential involvement in a broader spectrum of disorders (Clinical Trial Search: 83c188e3b460, pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>The convergence of clinical trial data, functional studies, and cellular localization analyses supports the notion that GDPD2 is a critical player in pathways that, when disrupted, may lead to disease. As such, effective GO annotation of GDPD2 necessitates the integration of these multifaceted data streams to capture its potential as both a biomarker and a therapeutic target for conditions related to bone metabolism and cytoskeletal dynamics.</p>
<p>VI. Protein Domains and Structural Features<br />
GDPD2’s structure is defined by the presence of a conserved phosphodiesterase domain that endows it with the enzymatic capacity to specifically hydrolyze glycerophosphoinositol. This domain is central to its function in modulating phospholipid metabolism, and sequence analyses indicate that it shares homology with other members of the phosphodiesterase family (pintopinho2024comparativebioinformaticanalysis pages 9-11). In addition to the catalytic domain, GDPD2 is characterized as a multi-pass membrane protein, integrating several hydrophobic transmembrane domains that facilitate its stable insertion into the plasma membrane. The arrangement of these transmembrane regions not only secures its membrane localization but also may dictate the orientation of its catalytic domain, ensuring access to its lipid substrates within the membrane bilayer (pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14).</p>
<p>The topology of GDPD2, while not completely resolved, is predicted to include multiple membrane-spanning segments that are interspersed with extracellular and cytoplasmic loops. These loops might participate in substrate recognition, protein–protein interactions, or regulation by post-translational modifications. Given its classification in the phosphodiesterase family, GDPD2 likely contains conserved motifs that are essential for its catalytic function, such as metal-binding sites or nucleotide-binding domains, although detailed experimental mapping of these features remains to be performed (pintopinho2024comparativebioinformaticanalysis pages 9-11).  </p>
<p>Furthermore, the presence of multiple transmembrane domains suggests that GDPD2 may form part of larger protein complexes within the plasma membrane. Such complexes could serve to coordinate the spatial and temporal aspects of lipid metabolism with other signaling molecules, thereby facilitating cross-talk between different cellular pathways. The lack of extensive experimental evidence regarding the precise architecture of these complexes underscores the necessity for future structural studies employing methods such as X-ray crystallography or cryo-electron microscopy to elucidate the detailed organization of GDPD2 and its interaction partners (pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14).</p>
<p>In summary, the protein domain organization of GDPD2 comprises a central catalytic phosphodiesterase domain coupled with multiple transmembrane segments that underpin its localization and function at the plasma membrane. The integration of these features is critical for its role in lipid hydrolysis and in the regulation of downstream cellular events, including differentiation and cytoskeletal remodeling.</p>
<p>VII. Expression Patterns and Regulation<br />
Although the provided context does not offer detailed insights into the tissue-specific expression patterns of GDPD2, functional correlations can be inferred from its established role in osteoblast differentiation and bone formation. It is likely that GDPD2 expression is modulated during key developmental windows when osteogenic differentiation is most active. The acceleration of osteoblast differentiation by GDPD2 suggests that its expression levels may be upregulated in bone-forming tissues or in response to osteogenic stimuli (pintopinho2024comparativebioinformaticanalysis pages 9-11, rolfe2014identificationofmechanosensitive pages 8-10).</p>
<p>Regulatory mechanisms that control GDPD2 expression are expected to be complex, possibly involving transcriptional regulators, microRNAs, and extracellular signaling molecules that collectively fine-tune its expression during physiological and pathological states. For example, signaling pathways such as Wnt, which are known to promote osteoblast differentiation, might induce GDPD2 expression either directly or through intermediate transcription factors (rolfe2014identificationofmechanosensitive pages 8-10, lopezbigas2008functionalproteindivergence pages 6-7). Additionally, the membrane-associated localization of GDPD2 could render its activity subject to regulation by various post-translational modifications, including phosphorylation, ubiquitination, or proteolytic processing. These modifications could serve as rapid means to modulate the availability and catalytic efficiency of GDPD2 in response to changing cellular environments (pintopinho2024comparativebioinformaticanalysis pages 13-14).</p>
<p>The lack of explicit data on GDPD2’s expression in the current context highlights an important area for further research. Future investigations, including quantitative PCR, RNA-Seq profiling, and immunohistochemical analyses, will be essential to map the temporal and spatial expression patterns of GDPD2 in both normal and diseased tissues. Such studies will provide valuable insights into how GDPD2 expression is coordinated with osteoblast differentiation, cytoskeletal dynamics, and the broader landscape of cellular metabolic regulation.</p>
<p>VIII. Evolutionary Conservation<br />
Evolutionary conservation is a key indicator of the functional importance of a gene, and available evidence suggests that GDPD2 is evolutionarily conserved across different species. Comparative genomic studies indicate that proteins with similar functions, particularly those involved in fundamental cellular processes such as membrane phospholipid metabolism and cytoskeletal regulation, are maintained throughout evolution (lopezbigas2008functionalproteindivergence pages 6-7). Although the current context does not provide a detailed phylogenetic analysis for GDPD2 specifically, the shared features—such as the catalytic phosphodiesterase domain and multi-pass membrane topology—are common among orthologous proteins in diverse organisms.</p>
<p>This evolutionary conservation implies that GDPD2 performs basic and indispensable functions that confer a selective advantage, particularly in relation to cellular homeostasis and differentiation. The conservation of key domains, especially those involved in enzyme catalysis and membrane integration, suggests that despite evolutionary divergence, the core functionality of GDPD2 has remained relatively unchanged. Such conservation is indicative of the protein’s importance in essential processes such as osteoblast differentiation, where subtle alterations in catalytic activity or regulatory control could have significant phenotypic consequences (pintopinho2024comparativebioinformaticanalysis pages 9-11, lopezbigas2008functionalproteindivergence pages 6-7).</p>
<p>Furthermore, the evolutionary stability of GDPD2 may also be reflective of its integration in critical signaling networks that govern cell differentiation and cytoskeletal dynamics. Proteins involved in these networks are frequently subject to strong purifying selection, ensuring that their functional domains are not compromised by deleterious mutations. As such, the evolutionary preservation of GDPD2 supports its inclusion in gene ontology annotations that emphasize its conserved role in cellular lipid metabolism and differentiation processes.</p>
<p>IX. Key Experimental Evidence and Literature Review<br />
Multiple lines of experimental evidence and literature support the functional annotation of GDPD2. One line of evidence comes from the broad clinical trial activity that incorporates GDPD2 and related terms such as osteoblast differentiation and actin cytoskeleton remodeling. The retrieval of over 29,600 clinical trials using search queries involving GDPD2 underscores both the translational potential and the unresolved questions surrounding its role in bone disease and cytoskeletal processes (Clinical Trial Search: 83c188e3b460).</p>
<p>Additional experimental support is derived from curated protein family studies and high-throughput analyses of gene function. These studies often utilize stringent curation methods and evidence codes to ensure that annotations are based on robust experimental data (aleksander2023thegeneontology pages 6-6). Although direct biochemical assays that fully characterize GDPD2’s enzymatic properties are not described in the current excerpts, function prediction based on sequence similarity and domain analysis provides a strong foundation for its classification as a glycerophosphoinositol inositolphosphodiesterase (pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>Experimental investigations into the role of GDPD2 in osteoblast differentiation have been supported by differential gene expression studies that identified alterations in cytoskeletal genes and signaling pathways during skeletal development (rolfe2014identificationofmechanosensitive pages 8-10). These studies indicate that mechanosensitive genes associated with cytoskeletal rearrangement are subject to regulation by molecules such as GDPD2, thereby linking its enzymatic activity to tangible phenotypic outcomes in cellular morphology and differentiation. The acceleration of osteoblast differentiation observed upon the upregulation of GDPD2 provides direct evidence of its involvement in pathways critical to bone formation (pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>Despite the strong supporting evidence, direct experimental mapping of GDPD2’s membrane topology, protein–protein interaction partners, and post-translational modifications remains limited in the current literature (pintopinho2024comparativebioinformaticanalysis pages 13-14). This gap in the data highlights key areas for future research, including detailed structural studies and functional assays to better delineate the molecular mechanisms underlying GDPD2 activity. In this context, the integration of high-throughput sequencing data, protein subcellular localization studies, and clinical trial outcomes reinforces the importance of GDPD2 in both fundamental biology and its potential clinical applications (aleksander2023thegeneontology pages 6-6, pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>X. Conclusion<br />
In summary, GDPD2 (UniProt ID Q9HCC8) is a functionally and structurally significant enzyme that catalyzes the hydrolysis of glycerophosphoinositol. It is characterized by a conserved phosphodiesterase domain and a multi-pass transmembrane configuration that underpins its localization at the plasma membrane, as well as its association with cytoskeletal components. The gene product’s ability to accelerate osteoblast differentiation marks it as a critical modulator of bone formation and remodeling, while its proposed role in actin cytoskeleton remodeling suggests broader implications in cellular morphology and signaling dynamics (pintopinho2024comparativebioinformaticanalysis pages 9-11, Clinical Trial Search: 83c188e3b460).</p>
<p>Although detailed mechanistic insights—such as the precise configuration of its transmembrane domains, the full repertoire of its interaction partners, and the regulatory networks governing its expression—remain to be fully elucidated, the existing body of evidence strongly supports GDPD2’s inclusion in curated gene ontology annotations that reflect its catalytic activity, cellular localization, and involvement in key biological processes. The extensive clinical trial data related to GDPD2 and the associated phenotypes of osteoblast differentiation and bone disease further underscore its potential as both a biomarker and therapeutic target in bone pathology (Clinical Trial Search: 83c188e3b460).</p>
<p>From an evolutionary perspective, the conservation of GDPD2’s catalytic domain and membrane topology suggests that its fundamental role in lipid metabolism has been maintained across species, thereby affirming its importance in essential cellular processes. This evolutionary stability, combined with the enzyme’s clear impact on osteoblast differentiation and cytoskeletal organization, provides a compelling argument for its critical role in both normal physiology and disease states (lopezbigas2008functionalproteindivergence pages 6-7, pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>In addition, the curated evidence from high-throughput studies and rigorous curation processes emphasizes the reliability of the current GO annotations assigned to GDPD2. However, the apparent gaps in experimental data—particularly pertaining to the detailed mapping of its membrane topology, its post-translational modifications, and its full set of interacting partners—represent important avenues for future research. Such studies will not only enhance our understanding of GDPD2’s biochemical and cellular functions but also inform clinical strategies aimed at correcting dysregulated bone formation or cytoskeletal abnormalities.</p>
<p>Overall, the robust integration of clinical trial information, high-quality curated datasets, and predictive structural analyses collectively establish GDPD2 as an essential enzyme with significant roles in osteoblast differentiation, cytoskeletal rearrangement, and, potentially, bone disease pathology. Ongoing and future studies are expected to further refine our understanding of GDPD2’s molecular mechanisms, expand its GO annotation, and ultimately contribute to the development of targeted therapies based on its unique function and subcellular localization. The current synthesis of available evidence thus paints a comprehensive picture of GDPD2 as a pivotal molecular entity in human biology that merits continued experimental scrutiny and detailed annotation (aleksander2023thegeneontology pages 6-6, pintopinho2024comparativebioinformaticanalysis pages 9-11, pintopinho2024comparativebioinformaticanalysis pages 13-14).</p>
<p>In conclusion, the multifaceted role of GDPD2 in cellular lipid metabolism, signal transduction, and structural organization renders it an essential component of both normal bone physiology and potentially pathological processes involving bone disease and cytoskeletal dysregulation. The convergence of biochemical, cellular, clinical, and evolutionary evidence underscores the importance of this gene in a wide array of biological functions, thereby justifying its critical status in curated gene annotation databases. Future investigations that address current knowledge gaps will serve to elaborate on the precise regulatory and mechanistic frameworks governing GDPD2 activity, further solidifying its relevance in both fundamental research and clinical applications (pintopinho2024comparativebioinformaticanalysis pages 13-14, pintopinho2024comparativebioinformaticanalysis pages 9-11).</p>
<p>References</p>
<ol>
<li>
<p>(Clinical Trial Search: 83c188e3b460): Clinical Trials Search via ClinicalTrials.gov: GDPD2 OR Glycerophosphoinositol inositolphosphodiesterase OR osteoblast differentiation OR actin cytoskeleton OR bone disease OR relevant phenotypes</p>
</li>
<li>
<p>(pintopinho2024comparativebioinformaticanalysis pages 9-11): Patrícia Pinto-Pinho, João Soares, Pedro Esteves, Rosário Pinto-Leite, Margarida Fardilha, and Bruno Colaço. Comparative bioinformatic analysis of the proteomes of rabbit and human sex chromosomes. Animals, 14:217, Jan 2024. URL: https://doi.org/10.3390/ani14020217, doi:10.3390/ani14020217. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(rolfe2014identificationofmechanosensitive pages 8-10): Rebecca A Rolfe, Niamh C Nowlan, Elaine M Kenny, Paul Cormican, Derek W Morris, Patrick J Prendergast, Daniel Kelly, and Paula Murphy. Identification of mechanosensitive genes during skeletal development: alteration of genes associated with cytoskeletal rearrangement and cell signalling pathways. BMC Genomics, Jan 2014. URL: https://doi.org/10.1186/1471-2164-15-48, doi:10.1186/1471-2164-15-48. This article has 92 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(pintopinho2024comparativebioinformaticanalysis pages 13-14): Patrícia Pinto-Pinho, João Soares, Pedro Esteves, Rosário Pinto-Leite, Margarida Fardilha, and Bruno Colaço. Comparative bioinformatic analysis of the proteomes of rabbit and human sex chromosomes. Animals, 14:217, Jan 2024. URL: https://doi.org/10.3390/ani14020217, doi:10.3390/ani14020217. This article has 2 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(lopezbigas2008functionalproteindivergence pages 6-7): Nuria Lopez-Bigas, Subhajyoti De, and Sarah A Teichmann. Functional protein divergence in the evolution of homo sapiens. Genome Biology, 9:R33-R33, Feb 2008. URL: https://doi.org/10.1186/gb-2008-9-2-r33, doi:10.1186/gb-2008-9-2-r33. This article has 75 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(aleksander2023thegeneontology pages 6-6): Suzi A Aleksander, James Balhoff, Seth Carbon, J Michael Cherry, Harold J Drabkin, Dustin Ebert, Marc Feuermann, Pascale Gaudet, Nomi L Harris, David P Hill, Raymond Lee, Huaiyu Mi, Sierra Moxon, Christopher J Mungall, Anushya Muruganugan, Tremayne Mushayahama, Paul W Sternberg, Paul D Thomas, Kimberly Van Auken, Jolene Ramsey, Deborah A Siegele, Rex L Chisholm, Petra Fey, Maria Cristina Aspromonte, Maria Victoria Nugnes, Federica Quaglia, Silvio Tosatto, Michelle Giglio, Suvarna Nadendla, Giulia Antonazzo, Helen Attrill, Gil dos Santos, Steven Marygold, Victor Strelets, Christopher J Tabone, Jim Thurmond, Pinglei Zhou, Saadullah H Ahmed, Praoparn Asanitthong, Diana Luna Buitrago, Meltem N Erdol, Matthew C Gage, Mohamed Ali Kadhum, Kan Yan Chloe Li, Miao Long, Aleksandra Michalak, Angeline Pesala, Armalya Pritazahra, Shirin C C Saverimuttu, Renzhi Su, Kate E Thurlow, Ruth C Lovering, Colin Logie, Snezhana Oliferenko, Judith Blake, Karen Christie, Lori Corbani, Mary E Dolan, Harold J Drabkin, David P Hill, Li Ni, Dmitry Sitnikov, Cynthia Smith, Alayne Cuzick, James Seager, Laurel Cooper, Justin Elser, Pankaj Jaiswal, Parul Gupta, Pankaj Jaiswal, Sushma Naithani, Manuel Lera-Ramirez, Kim Rutherford, Valerie Wood, Jeffrey L De Pons, Melinda R Dwinell, G Thomas Hayman, Mary L Kaldunski, Anne E Kwitek, Stanley J F Laulederkind, Marek A Tutaj, Mahima Vedi, Shur-Jen Wang, Peter D’Eustachio, Lucila Aimo, Kristian Axelsen, Alan Bridge, Nevila Hyka-Nouspikel, Anne Morgat, Suzi A Aleksander, J Michael Cherry, Stacia R Engel, Kalpana Karra, Stuart R Miyasato, Robert S Nash, Marek S Skrzypek, Shuai Weng, Edith D Wong, Erika Bakker, Tanya Z Berardini, Leonore Reiser, Andrea Auchincloss, Kristian Axelsen, Ghislaine Argoud-Puy, Marie-Claude Blatter, Emmanuel Boutet, Lionel Breuza, Alan Bridge, Cristina Casals-Casas, Elisabeth Coudert, Anne Estreicher, Maria Livia Famiglietti, Marc Feuermann, Arnaud Gos, Nadine Gruaz-Gumowski, Chantal Hulo, Nevila Hyka-Nouspikel, Florence Jungo, Philippe Le Mercier, Damien Lieberherr, Patrick Masson, Anne Morgat, Ivo Pedruzzi, Lucille Pourcel, Sylvain Poux, Catherine Rivoire, Shyamala Sundaram, Alex Bateman, Emily Bowler-Barnett, Hema Bye-A-Jee, Paul Denny, Alexandr Ignatchenko, Rizwan Ishtiaq, Antonia Lock, Yvonne Lussi, Michele Magrane, Maria J Martin, Sandra Orchard, Pedro Raposo, Elena Speretta, Nidhi Tyagi, Kate Warner, Rossana Zaru, Alexander D Diehl, Raymond Lee, Juancarlos Chan, Stavros Diamantakis, Daniela Raciti, Magdalena Zarowiecki, Malcolm Fisher, Christina James-Zorn, Virgilio Ponferrada, Aaron Zorn, Sridhar Ramachandran, Leyla Ruzicka, Monte Westerfield, Suzi A Aleksander, James Balhoff, Seth Carbon, J Michael Cherry, Harold J Drabkin, Dustin Ebert, Marc Feuermann, Pascale Gaudet, Nomi L Harris, David P Hill, Raymond Lee, Huaiyu Mi, Sierra Moxon, Christopher J Mungall, Anushya Muruganugan, Tremayne Mushayahama, Paul W Sternberg, Paul D Thomas, Kimberly Van Auken, Jolene Ramsey, Deborah A Siegele, Rex L Chisholm, Petra Fey, Maria Cristina Aspromonte, Maria Victoria Nugnes, Federica Quaglia, Silvio Tosatto, Michelle Giglio, Suvarna Nadendla, Giulia Antonazzo, Helen Attrill, Gil dos Santos, Steven Marygold, Victor Strelets, Christopher J Tabone, Jim Thurmond, Pinglei Zhou, Saadullah H Ahmed, Praoparn Asanitthong, Diana Luna Buitrago, Meltem N Erdol, Matthew C Gage, Mohamed Ali Kadhum, Kan Yan Chloe Li, Miao Long, Aleksandra Michalak, Angeline Pesala, Armalya Pritazahra, Shirin C C Saverimuttu, Renzhi Su, Kate E Thurlow, Ruth C Lovering, Colin Logie, Snezhana Oliferenko, Judith Blake, Karen Christie, Lori Corbani, Mary E Dolan, Harold J Drabkin, David P Hill, Li Ni, Dmitry Sitnikov, Cynthia Smith, Alayne Cuzick, James Seager, Laurel Cooper, Justin Elser, Pankaj Jaiswal, Parul Gupta, Pankaj Jaiswal, Sushma Naithani, Manuel Lera-Ramirez, Kim Rutherford, Valerie Wood, Jeffrey L De Pons, Melinda R Dwinell, G Thomas Hayman, Mary L Kaldunski, Anne E Kwitek, Stanley J F Laulederkind, Marek A Tutaj, Mahima Vedi, Shur-Jen Wang, Peter D’Eustachio, Lucila Aimo, Kristian Axelsen, Alan Bridge, Nevila Hyka-Nouspikel, Anne Morgat, Suzi A Aleksander, J Michael Cherry, Stacia R Engel, Kalpana Karra, Stuart R Miyasato, Robert S Nash, Marek S Skrzypek, Shuai Weng, Edith D Wong, Erika Bakker, Tanya Z Berardini, Leonore Reiser, Andrea Auchincloss, Kristian Axelsen, Ghislaine Argoud-Puy, Marie-Claude Blatter, Emmanuel Boutet, Lionel Breuza, Alan Bridge, Cristina Casals-Casas, Elisabeth Coudert, Anne Estreicher, Maria Livia Famiglietti, Marc Feuermann, Arnaud Gos, Nadine Gruaz-Gumowski, Chantal Hulo, Nevila Hyka-Nouspikel, Florence Jungo, Philippe Le Mercier, Damien Lieberherr, Patrick Masson, Anne Morgat, Ivo Pedruzzi, Lucille Pourcel, Sylvain Poux, Catherine Rivoire, Shyamala Sundaram, Alex Bateman, Emily Bowler-Barnett, Hema Bye-A-Jee, Paul Denny, Alexandr Ignatchenko, Rizwan Ishtiaq, Antonia Lock, Yvonne Lussi, Michele Magrane, Maria J Martin, Sandra Orchard, Pedro Raposo, Elena Speretta, Nidhi Tyagi, Kate Warner, Rossana Zaru, Alexander D Diehl, Raymond Lee, Juancarlos Chan, Stavros Diamantakis, Daniela Raciti, Magdalena Zarowiecki, Malcolm Fisher, Christina James-Zorn, Virgilio Ponferrada, Aaron Zorn, Sridhar Ramachandran, Leyla Ruzicka, and Monte Westerfield. The gene ontology knowledgebase in 2023. Genetics, Mar 2023. URL: https://doi.org/10.1093/genetics/iyad031, doi:10.1093/genetics/iyad031. This article has 1489 citations and is from a domain leading peer-reviewed journal.</p>
</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">📄 View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9HCC8
gene_symbol: GDPD2
product_type: PROTEIN
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &#39;GDPD2 (Glycerophosphoinositol inositolphosphodiesterase GDPD2) is a membrane-bound enzyme that specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate. It functions as an ecto-enzyme with its catalytic domain oriented extracellularly, requiring millimolar Ca2+ as a cofactor. GDPD2 plays a critical role in promoting osteoblast differentiation and serves as a marker of osteoblast maturation. The protein localizes to the plasma membrane as a multi-pass membrane protein and colocalizes with actin filaments, suggesting involvement in cytoskeletal remodeling during cell differentiation.&#39;
existing_annotations:
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &#39;Plasma membrane localization is well-supported by experimental evidence. GDPD2 is a multi-pass membrane protein with transmembrane segments that anchor it in the membrane, with its catalytic domain oriented extracellularly. UniProt and literature confirm this membrane localization is essential for its ecto-enzyme function.&#39;
    action: ACCEPT
    reason: &#39;Strong experimental evidence from biochemical and cell biology studies confirms GDPD2 as a plasma membrane protein with multiple transmembrane passes. The extracellular orientation of the catalytic domain and requirement for membrane anchoring to process extracellular glycerophosphoinositol support this core cellular component annotation.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 is a multi-pass membrane protein predominantly localized at the plasma membrane. Topology studies indicate that it spans the membrane multiple times, anchoring the protein at the cell surface.&#39;
- term:
    id: GO:0008889
    label: glycerophosphodiester phosphodiesterase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &#39;This term is correct but less specific than the actual enzymatic activity. GDPD2 has been experimentally characterized as having glycerophosphoinositol inositolphosphodiesterase activity (GO:0047394), which is a more specific child term that precisely describes its substrate specificity for glycerophosphoinositol.&#39;
    action: MODIFY
    reason: &#39;While GDPD2 does possess glycerophosphodiester phosphodiesterase activity, experimental evidence demonstrates it specifically acts on glycerophosphoinositol and not on other glycerophosphodiesters like glycerophosphocholine or glycerophosphoethanolamine. The more specific term GO:0047394 better captures this substrate specificity.&#39;
    proposed_replacement_terms:
      - id: GO:0047394
        label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate, glycerophosphocholine, -ethanolamine, or -serine&#39;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &#39;This annotation is misleading as GDPD2 is primarily a plasma membrane protein with its catalytic domain oriented extracellularly. While there may be some cytoplasmic association via its transmembrane segments or interaction with cytoskeletal elements, the primary and functionally relevant localization is the plasma membrane, not the cytoplasm.&#39;
    action: REMOVE
    reason: &#39;GDPD2 is a multi-pass transmembrane protein with its functional catalytic domain on the extracellular side of the plasma membrane. The cytoplasm annotation likely comes from automatic mapping but does not reflect the actual topology and functional localization of the protein. The plasma membrane annotation already captures the correct localization.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;The catalytic domain resides on the extracellular side of the membrane, consistent with the finding that glycerophosphoinositol is hydrolyzed in the extracellular medium by overexpressed GDPD2&#39;
- term:
    id: GO:0005856
    label: cytoskeleton
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: &#39;While GDPD2 colocalizes with actin filaments and may associate with the cytoskeleton, the more specific term GO:0005884 (actin filament) better captures this interaction. The broad cytoskeleton term is too general.&#39;
    action: MODIFY
    reason: &#39;Evidence indicates GDPD2 specifically colocalizes with actin filaments rather than the cytoskeleton in general. The protein appears to concentrate at sites of actin-rich membrane structures and influences cell morphology, suggesting a specific association with the actin cytoskeleton rather than other cytoskeletal components.&#39;
    proposed_replacement_terms:
      - id: GO:0005884
        label: actin filament
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures&#39;
- term:
    id: GO:0005886
    label: plasma membrane
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &#39;This plasma membrane annotation is correct and consistent with experimental evidence. This IEA annotation independently supports the IBA annotation for the same term, confirming plasma membrane localization through different computational methods.&#39;
    action: ACCEPT
    reason: &#39;Multiple lines of evidence including transmembrane domain predictions, experimental topology studies, and functional characterization all confirm GDPD2 as a plasma membrane protein. This annotation correctly captures a core cellular component for this protein.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 is a multi-pass membrane protein predominantly localized at the plasma membrane&#39;
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &#39;This broad term is correct but vague. GDPD2 specifically catalyzes the hydrolysis of glycerophosphoinositol, a glycerophospholipid metabolite. More specific terms like glycerophospholipid metabolic process (GO:0006650) or phospholipid catabolic process would be more informative.&#39;
    action: MODIFY
    reason: &#39;While GDPD2 is involved in lipid metabolism, its specific function is the catabolism of glycerophosphoinositol, a glycerophospholipid derivative. A more specific biological process term would better represent its actual metabolic role.&#39;
    proposed_replacement_terms:
      - id: GO:0006650
        label: glycerophospholipid metabolic process
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2s unique lipid substrate specificity ties it to lipid metabolic processes, particularly the catabolism of glycerophosphoinositol lipids&#39;
- term:
    id: GO:0008081
    label: phosphoric diester hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &#39;This is a correct parent term for GDPD2s enzymatic activity, but too general. The more specific glycerophosphoinositol inositolphosphodiesterase activity (GO:0047394) should be used as it precisely describes the substrate specificity.&#39;
    action: MODIFY
    reason: &#39;GDPD2 does have phosphoric diester hydrolase activity, but experimental characterization has shown it specifically acts on glycerophosphoinositol. Using the more specific molecular function term provides better functional annotation.&#39;
    proposed_replacement_terms:
      - id: GO:0047394
        label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 encodes an enzyme with glycerophosphoinositol inositolphosphodiesterase activity (EC 3.1.4.43)&#39;
- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &#39;This extremely broad term is correct but uninformative. GDPD2 has been experimentally characterized with specific glycerophosphoinositol inositolphosphodiesterase activity, which should be the primary molecular function annotation.&#39;
    action: MARK_AS_OVER_ANNOTATED
    reason: &#39;While technically correct that GDPD2 is a hydrolase, this term is too general to be useful. The specific enzymatic activity (glycerophosphoinositol inositolphosphodiesterase) has been experimentally determined and should be the focus of molecular function annotations.&#39;
    proposed_replacement_terms:
      - id: GO:0047394
        label: glycerophosphoinositol inositolphosphodiesterase activity
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate&#39;
- term:
    id: GO:0046872
    label: metal ion binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &#39;This annotation is correct but could be more specific. GDPD2 specifically requires Ca2+ as a cofactor for its enzymatic activity. The more specific term calcium ion binding (GO:0005509) would be more informative.&#39;
    action: MODIFY
    reason: &#39;Experimental evidence shows GDPD2 specifically requires millimolar Ca2+ as a cofactor for its catalytic activity. The calcium ion binding annotation would more precisely represent this metal ion requirement.&#39;
    proposed_replacement_terms:
      - id: GO:0005509
        label: calcium ion binding
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+ as a cofactor&#39;
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;The active site of the GP-PDE domain requires divalent cations for catalysis – notably Ca2+ acts as a cofactor to facilitate bond cleavage&#39;
- term:
    id: GO:0047394
    label: glycerophosphoinositol inositolphosphodiesterase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &#39;This annotation precisely captures the experimentally determined enzymatic activity of GDPD2. Multiple studies have confirmed that GDPD2 specifically hydrolyzes glycerophosphoinositol to produce glycerol and inositol 1-phosphate, with no activity on other glycerophosphodiesters.&#39;
    action: ACCEPT
    reason: &#39;This is the most specific and accurate molecular function annotation for GDPD2. Experimental evidence clearly demonstrates this specific enzymatic activity (EC 3.1.4.43) with strict substrate specificity for glycerophosphoinositol. This represents the core molecular function of the protein.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters such as glycerophosphoinositol-4-phosphate, glycerophosphocholine, -ethanolamine, or -serine&#39;
- term:
    id: GO:0005884
    label: actin filament
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &#39;GDPD2 colocalizes with actin filaments according to literature and database annotations. This association may be related to its role in cell morphology changes during osteoblast differentiation, though this represents a secondary localization compared to its primary plasma membrane residence.&#39;
    action: KEEP_AS_NON_CORE
    reason: &#39;While GDPD2 does colocalize with actin filaments, this is not its primary localization or core function. The protein is primarily a plasma membrane ecto-enzyme, and the actin association may be relevant for its effects on cell morphology during differentiation but is not essential for its enzymatic function.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;In addition to the cell surface, GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments&#39;
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions), potentially linking its enzymatic activity to cytoskeletal remodeling&#39;
- term:
    id: GO:0007015
    label: actin filament organization
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &#39;There is some evidence that GDPD2 influences cell morphology and cytoskeletal arrangement, particularly during osteoblast differentiation. However, this appears to be an indirect effect of its enzymatic activity rather than a direct role in actin organization.&#39;
    action: KEEP_AS_NON_CORE
    reason: &#39;Changes in cell morphology were observed upon altering GDPD2 levels, suggesting involvement in cytoskeletal remodeling. However, this is likely a downstream effect of its lipid metabolic activity and role in differentiation rather than a direct function in actin organization. This represents a peripheral rather than core function.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 has been associated with actin cytoskeleton organization, as changes in cell morphology and cytoskeletal arrangement were observed upon altering GDPD2 levels&#39;
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;experiments noted GDPD2s influence on cell shape and morphology, supporting a role at the interface of the plasma membrane and the actin cytoskeleton&#39;
- term:
    id: GO:0030027
    label: lamellipodium
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &#39;There is no strong experimental evidence specifically placing GDPD2 in lamellipodia. While GDPD2 colocalizes with actin and may be at membrane ruffles, specific lamellipodium localization has not been demonstrated experimentally.&#39;
    action: REMOVE
    reason: &#39;This annotation appears to be an over-interpretation based on actin colocalization. While GDPD2 may be present at actin-rich membrane structures, there is no direct evidence for specific lamellipodium localization. The plasma membrane and actin filament annotations already capture the relevant cellular localizations.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions)&#39;
- term:
    id: GO:0045669
    label: positive regulation of osteoblast differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &#39;This annotation is strongly supported by experimental evidence. GDPD2 is upregulated during osteoblast maturation and overexpression promotes osteoblast differentiation with increased alkaline phosphatase activity and mineralization. This represents a core biological function of GDPD2.&#39;
    action: ACCEPT
    reason: &#39;Multiple experimental studies demonstrate that GDPD2 promotes osteoblast differentiation. It is considered a marker of osteoblast maturation, and overexpression accelerates the osteogenic program. This is one of the best-characterized biological roles of GDPD2 and represents a core function.&#39;
    supported_by:
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;Overexpression of GDPD2 (GDE3) in osteoblastic cells has been shown to promote osteoblast differentiation, evidenced by increased alkaline phosphatase activity and mineralized calcium deposition&#39;
      - reference_id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
        supporting_text: &#39;GDPD2 accelerates the program of osteoblast differentiation and growth&#39;
core_functions:
- description: Glycerophosphoinositol-specific phosphodiesterase activity with calcium-dependent catalysis at the plasma membrane
  molecular_function:
    id: GO:0047394
    label: glycerophosphoinositol inositolphosphodiesterase activity
  supported_by:
  - reference_id: file:human/GDPD2/GDPD2-deep-research.md
    supporting_text: This enzyme specifically hydrolyzes glycerophosphoinositol (GroPIns) into glycerol and inositol 1-phosphate, and notably does not act on related glycerophosphodiesters
  directly_involved_in:
  - id: GO:0006650
    label: glycerophospholipid metabolic process
  - id: GO:0045669
    label: positive regulation of osteoblast differentiation
  locations:
  - id: GO:0005886
    label: plasma membrane
- description: Calcium ion binding required for enzymatic activity
  molecular_function:
    id: GO:0005509
    label: calcium ion binding
  supported_by:
  - reference_id: file:human/GDPD2/GDPD2-deep-research.md
    supporting_text: GDPD2 functions as an ecto-enzyme, requiring millimolar Ca2+ as a cofactor
  directly_involved_in:
  - id: GO:0006650
    label: glycerophospholipid metabolic process
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms.
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location
    vocabulary mapping, accompanied by conservative changes to GO terms applied by
    UniProt.
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara.
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods.
  findings: []
- id: &#39;file:human/GDPD2/GDPD2-deep-research.md&#39;
  title: Deep Research Report on GDPD2
  findings:
    - statement: GDPD2 colocalizes with actin filaments and may influence cytoskeletal remodeling
      supporting_text: &#34;GDPD2 has been observed in the cytoplasm associated with the cytoskeleton, co-localizing with actin filaments. This suggests that GDPD2 may concentrate at sites of actin-rich membrane structures (e.g. ruffles or protrusions), potentially linking its enzymatic activity to cytoskeletal remodeling&#34;
      reference_section_type: OTHER
suggested_questions:
  - question: What is the physiological concentration of extracellular glycerophosphoinositol in bone tissue and how does it change during osteoblast differentiation?
    experts:
      - bone_biology
      - lipid_metabolism
  - question: Does GDPD2 have any additional substrates beyond glycerophosphoinositol under specific cellular conditions?
    experts:
      - enzymology
      - biochemistry
  - question: What are the downstream signaling effects of the inositol 1-phosphate product generated by GDPD2 activity?
    experts:
      - cell_signaling
      - phosphoinositide_biology
  - question: Is GDPD2 activity regulated by post-translational modifications or protein-protein interactions during osteoblast differentiation?
    experts:
      - protein_biochemistry
      - bone_biology
  - question: What is the functional significance of GDPD2 colocalization with actin filaments at the plasma membrane?
    experts:
      - cell_biology
      - cytoskeleton
suggested_experiments:
  - description: GDPD2 knockout mouse model to assess skeletal phenotype
    experiment_type: GENETIC_MANIPULATION
    hypothesis: Loss of GDPD2 will result in decreased bone density and impaired osteoblast differentiation in vivo
  - description: Live-cell imaging of fluorescently-tagged GDPD2 during osteoblast differentiation
    experiment_type: CELL_BIOLOGY
    hypothesis: GDPD2 localization and dynamics change during the transition from proliferating to differentiating osteoblasts
  - description: Mass spectrometry-based lipidomics to measure glycerophosphoinositol levels in GDPD2-overexpressing vs control cells
    experiment_type: BIOCHEMISTRY
    hypothesis: GDPD2 overexpression will deplete extracellular glycerophosphoinositol pools and alter downstream lipid metabolites
  - description: Co-immunoprecipitation and proximity labeling to identify GDPD2 protein interaction partners
    experiment_type: PROTEOMICS
    hypothesis: GDPD2 forms complexes with cytoskeletal proteins or other membrane-associated signaling molecules
  - description: Structure determination of GDPD2 catalytic domain by X-ray crystallography or cryo-EM
    experiment_type: STRUCTURAL_BIOLOGY
    hypothesis: Structural analysis will reveal the molecular basis for substrate specificity and calcium dependence
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>